Journal article
ADGRV1 is implicated in myoclonic epilepsy
KA Myers, S Nasioulas, A Boys, JM McMahon, H Slater, P Lockhart, D du Sart, IE Scheffer
Epilepsia | WILEY | Published : 2018
DOI: 10.1111/epi.13980
Abstract
Objective: To investigate the significance of variation in ADGRV1 (also known as GPR98, MASS1, and VLGR1), MEF2C, and other genes at the 5q14.3 chromosomal locus in myoclonic epilepsy. Methods: We studied the epilepsy phenotypes of 4 individuals with 5q14.3 deletion and found that all had myoclonic seizures. We then screened 6 contiguous genes at 5q14.3, MEF2C, CETN3, MBLAC2, POLR3G, LYSMD3, and ADGRV1, in a 95-patient cohort with epilepsy and myoclonic seizures. Of these genes, point mutations in MEF2C cause a phenotype involving seizures and intellectual disability. A role for ADGRV1 in epilepsy has been proposed previously, based on a recessive mutation in the Frings mouse model of audiog..
View full abstractGrants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
Australian National Health and Medical Research Council Program, Grant/Award Number: 628952, 437027, GNT1032364; Victorian Government's Operational Infrastructure Support Program; Australian Government NHMRC IRIISS